SRS16-86 is a novel third generation ferrostatin, which is an inhibitor of ferroptosis.

 

Brand: BCM

 

Target: Ferroptosis

 

Signaling Pathways: Apoptosis

 

Boiling Point: 614.9±55.0 °C(Predicted)

 

pKa: 5.58±0.20(Predicted)

 

Solubility: Soluble in DMSO; Soluble in Ethanol. Insoluble in Water.

 

Isomeric SMILES: CC(C)(C)OC(=O)C1=CC(=C(C=C1)NC23CC4CC(C2)CC(C4)C3)N=CC5=CN=CN=C5  

 

InChIKey: DFENTOUMMDWZAF-UHFFFAOYSA-N  

 

InChI: InChI=1S/C26H32N4O2/c1-25(2,3)32-24(31)21-4-5-22(23(9-21)29-15-20-13-27-16-28-14-20)30-26-10-17-6-18(11-26)8-19(7-17)12-26/h4-5,9,13-19,30H,6-8,10-12H2,1-3H3

 

Attribute
[Chem Name]	tert-butyl 4-(1-adamantylamino)-3-(pyrimidin-5-ylmethylideneamino)benzoate
[Synonym]	SRS16-86
[CAS No.]	1793052-96-6
[MDL No.]	MFCD34187226
[Formula]	C26H32N4O2
[Molecular]	432.56
[Form]	Yellow solid
[Storage]	Sealed in dry, 2-8°C

Goods Tag